As the principal finding of the TRANSFER study, we here show for the first time that the site-specific absence of the transporter at the plasma membrane precludes a favorable overall survival, even if OCT1 is highly expressed in the cytosol of tumor cells. Here, SLC22A1 is linked to neoplasm.